Tag archive for ‘Science and technology in Israel’

Three way takeover battle: Abbott Labs to back Mylan’s acquisition of Perrigo

Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott Lab potentially helping Mylan forfend More...

Niva Goldberg On Sunday, June 14th, 2015

Qualcomm co-founder donates $50 million to Technion

Qualcomm cofounder Prof. Andrew Viterbi has announced that he is donating $50 million to secure and enhance the Technion-Israel Institute of Technology’s leadership position in electrical and computer engineering More...

Contributor On Tuesday, June 9th, 2015

Call to Students: ‘Practice Entrepreneurship in the Start-Up Nation’

The Technion’s New ‘Start-uP MBA’ Program Will Focus on Practical Application of Entrepreneurship, Innovation and Technology Management. The Technion-Israel Institute of Technology, one More...

Ilan Shavit On Tuesday, June 2nd, 2015

Mylan to Teva: stop playing games with our company

Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, but did not clarify which anti-trust rule More...

Shiri Habib-Valdhorn On Thursday, May 14th, 2015

Three way takeover battle- Teva: We can close Mylan deal in 2015

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) CFO Eyal Desheh remains upbeat about Teva’s attempts to buy Mylan N.V. (Nasdaq: MYL). At the same time, Mylan continues to oppose the takeover More...

Kurt Tucholsky On Wednesday, May 13th, 2015

Actavis CEO: Teva-Mylan Deal to Create ‘Bad Blood’, Destroy Value

    As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of rival drug manufacturer Actavis, has raised concerns More...

Shiri Habib-Valdhorn On Monday, May 11th, 2015

Teva rejected opportunity to acquire Perrigo

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) had an opportunity to acquire US pharmaceuticals company Perrigo Company (NYSE:PRGO; TASE:PRGO) a few months ago, and said it was not interested, More...

Reuters On Friday, May 8th, 2015

Three way takeover battle: Mylan chairman tells investors he would consider buying Teva

  Reuters Exclusive: Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to sell itself to Israeli rival Teva Pharmaceuticals Industries More...

Tali Tsipori On Tuesday, May 5th, 2015

Benny Landa: Teva would be wrong to buy Mylan

Benny Landa feels confused. The successful entrepreneur, one of the fathers of Israel’s digital printing equipment industry, does not quite understand why Israel’s Teva Pharmaceutical Industries More...

Shiri Habib-Valdhorn On Monday, May 4th, 2015

Mylan chairman due $72 million golden parachute

  Mylan (MYL), the generic pharmaceuticals company that is now the object of a hostile takeover bid from Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), reported its senior executives’ More...

Wordpress site Developed by Fixing WordPress Problems